These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

476 related items for PubMed ID: 10207643

  • 1. Participation in breast cancer susceptibility testing protocols: influence of recruitment source, altruism, and family involvement on women's decisions.
    Geller G, Doksum T, Bernhardt BA, Metz SA.
    Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 2):377-83. PubMed ID: 10207643
    [Abstract] [Full Text] [Related]

  • 2. Healthy women with a family history of breast cancer: impact of a tailored genetic counseling intervention on risk perception, knowledge, and menopausal therapy decision making.
    Matloff ET, Moyer A, Shannon KM, Niendorf KB, Col NF.
    J Womens Health (Larchmt); 2006 Sep; 15(7):843-56. PubMed ID: 16999640
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS.
    Oncologist; 1996 Sep; 1(5):326-330. PubMed ID: 10388011
    [Abstract] [Full Text] [Related]

  • 5. Interest in BRCA1/2 testing in a primary care population.
    Armstrong K, Weber B, Ubel PA, Guerra C, Schwartz JS.
    Prev Med; 2002 Jun; 34(6):590-5. PubMed ID: 12052018
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Factors associated with decisions about clinical BRCA1/2 testing.
    Armstrong K, Calzone K, Stopfer J, Fitzgerald G, Coyne J, Weber B.
    Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1251-4. PubMed ID: 11097234
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Genetic testing for breast cancer susceptibility: awareness and interest among women in the general population.
    Tambor ES, Rimer BK, Strigo TS.
    Am J Med Genet; 1997 Jan 10; 68(1):43-9. PubMed ID: 8986274
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Patients' resistance to risk information in genetic counseling for BRCA1/2.
    Gurmankin AD, Domchek S, Stopfer J, Fels C, Armstrong K.
    Arch Intern Med; 2005 Mar 14; 165(5):523-9. PubMed ID: 15767527
    [Abstract] [Full Text] [Related]

  • 13. Women's decisions regarding management of breast cancer risk.
    MacDonald DJ.
    Medsurg Nurs; 2002 Aug 14; 11(4):183-6. PubMed ID: 12219430
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Early adoption of BRCA1/2 testing: who and why.
    Armstrong K, Weiner J, Weber B, Asch DA.
    Genet Med; 2003 Aug 14; 5(2):92-8. PubMed ID: 12644778
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Intention to learn results of genetic testing for hereditary colon cancer.
    Vernon SW, Gritz ER, Peterson SK, Perz CA, Marani S, Amos CI, Baile WF.
    Cancer Epidemiol Biomarkers Prev; 1999 Apr 14; 8(4 Pt 2):353-60. PubMed ID: 10207640
    [Abstract] [Full Text] [Related]

  • 18. Assessing the knowledge and attitudes regarding genetic testing for breast cancer risk in our region of southeastern Georgia.
    MacNew HG, Rudolph R, Brower ST, Beck AN, Meister EA.
    Breast J; 2010 Apr 14; 16(2):189-92. PubMed ID: 20030654
    [Abstract] [Full Text] [Related]

  • 19. Fertility intentions following testing for a BRCA1 gene mutation.
    Smith KR, Ellington L, Chan AY, Croyle RT, Botkin JR.
    Cancer Epidemiol Biomarkers Prev; 2004 May 14; 13(5):733-40. PubMed ID: 15159303
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.